Previous close | 164.92 |
Open | 163.00 |
Bid | 0.00 x 900 |
Ask | 0.00 x 1200 |
Day's range | 162.82 - 166.22 |
52-week range | 155.72 - 186.69 |
Volume | |
Avg. volume | 6,997,210 |
Market cap | 432.801B |
Beta (5Y monthly) | 0.57 |
PE ratio (TTM) | 24.60 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 4.52 (2.74%) |
Ex-dividend date | 17 Feb 2023 |
1y target est | N/A |
Companies whose businesses were buoyed or boosted by Covid product demand are facing a cliff in 2023, and will have to pivot to more traditional strategies.
While there is no perfect dividend stock, Johnson & Johnson (NYSE: JNJ) is about as great as they come. Since its founding more than 130 years ago, J&J established itself as the leading pharmaceutical company in the world. Just how big is J&J?
The past year reminded investors how volatile the stock markets can be. Dividend stocks can earn you steady, passive income even during tough times, and if the stocks also regularly grow their dividends, you could even build a fortune over your lifetime. If the idea of buying such a dividend stock now to earn a lifetime of passive income appeals to you, here are three stocks to check out right away.